Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synaptophysin autoantibodies mediate synaptic dysfunction in cerebellar ataxia.

Cell reports. Medicine·2026
Same author

Aftiphilin Regulation of Myosin Light Chain Kinase Activity Promotes Actin Dynamics and Intestinal Epithelial Barrier Function.

Frontiers in gastroenterology (Lausanne, Switzerland)·2026
Same author

Mucosally sourced complement factor B modulates the host response to colitis.

bioRxiv : the preprint server for biology·2026
Same author

Rapid disassembly and Piwi-independent reassembly of <i>Drosophila</i> piRNA cluster heterochromatin following acute heat shock.

RNA (New York, N.Y.)·2025
Same author

Aub, Vasa, and Armi concentration in phase-separated nuage is dispensable for piRNA biogenesis and transposon silencing.

RNA (New York, N.Y.)·2025
Same author

Fidaxomicin Reduces Collagen Expression in Intestinal Fibroblasts Via Platelet-Derived Growth Factor Receptor Beta and Glycogen Synthase Kinase-3 Beta Inhibition.

Gastroenterology·2025

Related Experiment Video

Updated: May 18, 2026

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
06:57

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Published on: September 18, 2016

Antimicrobial peptides and colitis.

Samantha Ho1, Charalabos Pothoulakis, Hon Wai Koon

  • 1Inflammatory Bowel Disease Center, Division of Digestive Diseases, David Geffen School of Medicine, The University of California Los Angeles, Los Angeles, CA 90095, USA.

Current Pharmaceutical Design
|September 7, 2012
PubMed
Summary

Antimicrobial peptides (AMPs) are key to innate immunity, fighting gut infections and inflammation. Research explores their therapeutic potential for conditions like Inflammatory Bowel Disease (IBD), with new synthetic AMPs showing promise.

Related Experiment Videos

Last Updated: May 18, 2026

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
06:57

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Published on: September 18, 2016

Area of Science:

  • Innate Immunity
  • Gastroenterology
  • Microbiology

Background:

  • Antimicrobial peptides (AMPs) are crucial innate immune components, often upregulated during colonic inflammation and infection.
  • AMPs like beta defensins and cathelicidin are induced by gut microbial invasion, while others like alpha defensins are constitutively expressed.
  • Dysregulation of AMPs and autoantibodies against bactericidal/permeability-increasing protein (BPI) are linked to Inflammatory Bowel Disease (IBD).

Purpose of the Study:

  • To review recent advancements in antimicrobial peptides (AMPs) research.
  • To highlight the role of AMPs in innate immunity and the pathophysiology of colitis.
  • To explore the therapeutic potential of AMPs for inflammatory bowel disease.

Main Methods:

  • Literature review of current research on antimicrobial peptides.
  • Analysis of gene expression patterns of AMPs in response to gut microbial invasion.
  • Examination of the role of specific AMPs in modulating colitis and their potential as biomarkers.

Main Results:

  • AMPs exhibit diverse antimicrobial activities and varying roles in colitis modulation (e.g., cathelicidin) or disease activity indication (e.g., lactoferrin, hepcidin).
  • Altered defensin expression and anti-BPI autoantibodies are associated with Inflammatory Bowel Disease (IBD).
  • Natural AMPs (cathelicidin, elafin, SLPI) have shown efficacy in preclinical colitis models, and novel synthetic AMPs are under development.

Conclusions:

  • Antimicrobial peptides (AMPs) play a significant role in innate immunity and gut health.
  • AMPs hold therapeutic promise for inflammatory bowel disease, with ongoing development of novel peptide-based treatments.
  • Further research into AMPs could lead to new strategies for managing colitis and related gastrointestinal disorders.